RNA viruses as virotherapy agents.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 961, doi. 10.1038/sj.cgt.7700535
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2002 AND VI 9 AND IP 12
Results: 14
1
2
Biosafety and product release testing issues relevant to replication-competent oncolytic viruses.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 1056, doi. 10.1038/sj.cgt.7700536
- By:
- Publication type:
- Article
3
Oncolytic herpes simplex virus vectors for cancer virotherapy.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 967, doi. 10.1038/sj.cgt.7700537
- By:
- Publication type:
- Article
4
Virotherapy clinical trials for regional disease: In situ immune modulation using recombinant poxvirus vectors.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 1013, doi. 10.1038/sj.cgt.7700538
- By:
- Publication type:
- Article
5
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 979, doi. 10.1038/sj.cgt.7700539
- By:
- Publication type:
- Article
6
Principles of tumor immunosurveillance and implications for immunotherapy.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 1043, doi. 10.1038/sj.cgt.7700540
- By:
- Publication type:
- Article
7
Adenoviral vectors: Systemic delivery and tumor targeting.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 1036, doi. 10.1038/sj.cgt.7700541
- By:
- Publication type:
- Article
8
Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genes.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 1022, doi. 10.1038/sj.cgt.7700542
- By:
- Publication type:
- Article
9
Selectively replicating viral vectors.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 987, doi. 10.1038/sj.cgt.7700547
- By:
- Publication type:
- Article
10
The oncolytic virotherapy treatment platform for cancer: Unique biological and biosafety points to consider.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 1062, doi. 10.1038/sj.cgt.7700548
- By:
- Publication type:
- Article
11
Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 1001, doi. 10.1038/sj.cgt.7700549
- By:
- Publication type:
- Article
12
Virotherapy for cancer: Current status, hurdles, and future directions.
- Published in:
- 2002
- By:
- Publication type:
- Editorial
13
Volume 12 Author Index.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 1068
- Publication type:
- Article
14
Volume 12 Subject Index.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 12, p. 1072
- Publication type:
- Article